BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36948422)

  • 1. Association of type 1 diabetes mellitus and risk of atrial fibrillation: Systematic review and meta-analysis.
    Guo S; Huang Y; Liu X; Ma J; Zhu W
    Diabetes Res Clin Pract; 2023 May; 199():110629. PubMed ID: 36948422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.
    Aune D; Feng T; Schlesinger S; Janszky I; Norat T; Riboli E
    J Diabetes Complications; 2018 May; 32(5):501-511. PubMed ID: 29653902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
    Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
    Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increased risk of atrial fibrillation in inflammatory arthritis: a systematic review and meta-analysis of cohort studies.
    Ma Y; Pan Z; Fan D; Xu S; Pan F
    Immunol Invest; 2022 May; 51(4):1095-1107. PubMed ID: 33563055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological factors and risk of atrial fibrillation: A meta-analysis and systematic review.
    Wu H; Li C; Li B; Zheng T; Feng K; Wu Y
    Int J Cardiol; 2022 Sep; 362():85-92. PubMed ID: 35618103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease.
    Cai X; Li J; Cai W; Chen C; Ma J; Xie Z; Dong Y; Liu C; Xue R; Zhao J
    J Diabetes Complications; 2021 Apr; 35(4):107833. PubMed ID: 33514477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis.
    Bisson A; Bodin A; Fauchier G; Herbert J; Angoulvant D; Ducluzeau PH; Lip GYH; Fauchier L
    Cardiovasc Diabetol; 2021 Jan; 20(1):24. PubMed ID: 33482830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus increases risk of incident atrial fibrillation: A systematic review and meta-analysis.
    Chen Y; Fu L; Pu S; Xue Y
    Int J Rheum Dis; 2022 Oct; 25(10):1097-1106. PubMed ID: 35906745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis.
    Blum S; Meyre P; Aeschbacher S; Berger S; Auberson C; Briel M; Osswald S; Conen D
    Heart Rhythm; 2019 Apr; 16(4):502-510. PubMed ID: 30366160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies.
    Guo Y; Liu L; Wang J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31088901
    [No Abstract]   [Full Text] [Related]  

  • 11. Premature atrial complexes can predict atrial fibrillation in ischemic stroke patients: A systematic review and meta-analysis.
    Tao Y; Xu J; Gong X; Sun J; Yang D
    Pacing Clin Electrophysiol; 2021 Sep; 44(9):1599-1606. PubMed ID: 34170567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between psychological factors and atrial fibrillation: A meta-analysis and systematic review.
    Fu Y; He W; Ma J; Wei B
    Medicine (Baltimore); 2020 Apr; 99(16):e19615. PubMed ID: 32311930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis.
    Alijla F; Buttia C; Reichlin T; Razvi S; Minder B; Wilhelm M; Muka T; Franco OH; Bano A
    Cardiovasc Diabetol; 2021 Dec; 20(1):230. PubMed ID: 34876114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis.
    Shi W; Zhang W; Zhang D; Ren G; Wang P; Gao L; Chen H; Ding C
    Heart Rhythm; 2021 Jul; 18(7):1090-1096. PubMed ID: 33684547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis.
    Xu J; Sun Y; Gong D; Fan Y
    Front Endocrinol (Lausanne); 2022; 13():921159. PubMed ID: 35979438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations.
    Zheng Y; Xie Z; Li J; Chen C; Cai W; Dong Y; Xue R; Liu C
    BMC Cardiovasc Disord; 2021 Feb; 21(1):90. PubMed ID: 33588759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.
    Huxley RR; Filion KB; Konety S; Alonso A
    Am J Cardiol; 2011 Jul; 108(1):56-62. PubMed ID: 21529739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis.
    Jones NR; Taylor KS; Taylor CJ; Aveyard P
    Heart; 2019 Dec; 105(23):1799-1805. PubMed ID: 31229991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis.
    Corica B; Romiti GF; Raparelli V; Cangemi R; Basili S; Proietti M
    Europace; 2022 Oct; 24(9):1395-1403. PubMed ID: 35244694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs and incidence of atrial fibrillation: a meta-analysis.
    Chokesuwattanaskul R; Chiengthong K; Thongprayoon C; Lertjitbanjong P; Bathini T; Ungprasert P; Cato LD; Mao MA; Cheungpasitporn W
    QJM; 2020 Feb; 113(2):79-85. PubMed ID: 32031227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.